ArticlePharmaceuticals (Basel, Switzerland)2021

Pilot Sub-Study of the Effect of Hepatitis C Cure by Glecaprevir/Pibrentasvir on the Gut Microbiome of Patients with Chronic Hepatitis C Genotypes 1 to 6 in the Mythen Study.

Bahtiyar Yilmaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.